Canada’s proposed pharmacare plan risks limiting patient choice by replacing effective, personalized treatments with a narrow one-size-fits-all formulary. Innovative Medicines Canada warns this could harm those with chronic or complex conditions, restrict physician flexibility, and slow access to new medicines. Instead, reforms should close coverage gaps while preserving choice and access. Read the full article to learn why Canadians must be at the centre of pharmacare.